한양대학교 약학대학 김진기 교수|Hanyang University Professor Kim Jin Ki

1. 01Anthony J. Di Pasqua1, Hong Yuan, Younjee Chung, Jin-Ki Kim, James E Huckle, Chenxi Li, Matthew Sadgrove, Thanh Huyen Tran, Michael Jay, Xiuling Lu, Neutron-activatable holmium-containing mesoporous silica nanopartides as a potential radionuclide therapeutic agent for ovarian cancer. J. Nud. Med. 54(1), 111-115 (2013.01.01)
2. 02Jin-Ki Kim, Hong Yuan, Jingxin Nie, Markos Leggas, Philp M, Potter, John Rinehart, Michael Jay, Xiuling Lu, High payload dual therapeutic-imaging nanocarriers for triggered tumor delivery. Small 8(18), 2895-2903 (2012.09.24).
3. 03Anthony J. Di Pasqua, James E. Huckle, Jin-Ki Kim, Younjee Chung Andrew Z Wang Michael Jay, Xiuling Lu, Preparation of neutron-activatable holmium nanopartides for the treatment of ovarian cancer metastases. Small8(7), 997-1000 (2012.02.10)
4. 04Eun Kyung Oh, Su-Eon Jin, Jin-Ki Kim, Jeong-Sook Park, Youmie Park, Chong-Kook Kim, Retained topical delivery of 5-aminoevulinic acid using cationic ultradeformable liposom for photodynamic therapy. Eur. J. Pharm. Sci. 44(1-2), 149-157 (2011.09.18)
5. 05Jin-Ki Kim, Jun-Pil Jee, Jeong-Sook Park, Hyung Tae Kim, Chong-Kook Kim, Reverse-phase liquid chromatography with electrospray ionization/mass spectrometry for the quantification of pseudoephedrine in human plasma and application to a bioequivalence study. Arznemittelforschung 61(5), 276-281 (2011.05.30)
6. 06Viverk Kumar Garripelli, Jin-Ki Kim, SeJin Son, Won Jong Kim, Michael A Repka, Seongbong Jo, Matrix metalloproteinase-sensitive thermogelling polymer for bioresponsive local drug delivery. Acta Biomater. 7(2), 1984-1992 (2011.0507)
7. 07Dong II Kang Sukmook Lee, jung Tae lee, Byung Je Sung Ji-Yong Yoon, jin-Ki Kim, Junho Chung, Soo Jeong Lim, Preparation and in vitro evaluation of anti-VCAM-1Fab-conjugated liposomes for the targeted delivery of the poorly water-soluble drug celecoxib. J. Microencapsul. 28(3), 220-227 (2011.03).
8. 08Seo-Ryung Kim, Jin-ki kim, Jeng-Sook Park, Chong-Kook Kim, Dry elixir formulations of dexibuprofen for controlled release and enhanced oral bioavailability. Int J. Pharm. 404(1-2), 301-307 (2011.02.14).
9. 09Jin-Ki Kim, Melissa D. Howard, Thomas D. Dziubla, John J. Rinehart, Michael Jay, Xiuling Lu, Uniformity of drug payload and its effect on stability of solid lipid nanoparticle containing an ester prodrug ACS Naono 5(1), 209-216 (2011.01.25)
10. 10Jin-Ki Kim, Vivek Kumar Garripeli, Ui-Hyeon Jeong, Jeong-Sook Park, Michael A. Repka, Seongbong Jo, Novel pH-sensitive polyacetal-based block copolymers for controlled drug delivery. Int. j. Pharm. 401(1-2), 79-86 (2010.11.30)
11. 11Ye-Tae Kim, Baek-Ki Shin, Vivek K. Garripelli, JIn-Ki Kim, Enkhzaya Davaa, Seongbong Jo, Jeong-Sook Park, A thermosensitive vaginal gel formulation with HPCD for the pH-dependent release and solubilzation of amphotericin B. Eur. J. Pharm. Sci. 41(2), 399-406 (2010.10.09)
12. 12Vivek K Garripelli, Jin-Ki Kim, Ran Namgung, Won Jong Kim, Michael A. Repka, Seongbong Jo, A novel thermosensitive polymer with pH-dependent degradation for drug delivery. Acta Biomater. 6(2), 477-485 (2010.02.01)
13. 13Jin-Ki Kim, Jeong-Sook Park, Chong-Kook Kim, Development of a binary lipid nanopartides formulation of itraconazole for parenteral administration and controlled release. Int. J. Pharm. 383(1-2), 209-215 (2010.01.04)
14. 14Ji-Yong Kim, Jin-Ki Kim, Jeong-Sook Park, Yongro Byun, Chong-Kook Kim, The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator, Biomaterials 30(29), 5751-5756 (2009.10.01)
15. 15Seung-Hee Baek, Sung Jin Park, Su-Eon Jin, Jin-ki Kim, Chong-Kook Kim, Jeong-Min Hwang, Subconjunctivally injected, liposome-encapsulated streptokinase enhances the absorption rate of subconjunctival hemorrhages in rabbits. Eur. J. Pharm. Biopharm. 72(3), 546-551 (2009.08.01)
16. 16Jin-Ki Kim, Joel Anderson, Ho-Wook Jun, Michael A. Repka, Seongbong Jo, Self-assembling peptide amphiphile-based nanofiber gel for bioresponsive cisplatin delivery. Mol. Pharmaceutics 6(3), 978-985 (2009.05.01)
17. 17Jin-Ki Kim, Myong-Sun Kim, Jeong-Sook Park, Chong-Kook Kim, Thermo-reversible flurbiprofen liquid suppository with HP-B-CD as a solubility enhancer. Improvement of rectal bioavailability. J. Ind. Phenom. Macrocycl. Chem. 64(3-4), 265-272 (2009.03.13)
18. 18Sung-Hoon Kim, Jin-Ki Kim, Soo-Jeong Lim, jeong-Sook Park, Mi-Kyung Lee, Chong-Kook Kim, Folate-tethered emulsion for the target delivery of retinoids to cancer cells. Eur. J. Pharm. Biopharm. 68(3), 618-625 (2008.03.01)
19. 19Meong Cheol Shin, Jin-Ki Kim, Chong-Kook Kim, Bioequivalence evaluation of two brands of Lisinopril tablets by in vitro comparative dissolution test and in vivo bioequivalence test. Arzneimittelforschung 58(1), 11-17 (2008.01.30)
20. 20Yoonho Choi, Jin-Ki Kim, Eunmi Ban, Jeong-Sook Park, Chong-Kook Kim Determination of losartan in human plasma by liquid chromatography electrospray inonization mass spectrometry (LC-ESI-MS): application to bioequivalence study, J. Liq. Chromatogr. & Rel. Tech. 31(17), 2643-2656(2008.01.01)
21. 21JY Hong JK Kim, YK Song JS Park, CK Kim, A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption, J. Control. Release 110(2), 332-338 (2006.01.10)
22. 22HG Choi, BJ Park, JO Kim, Yj Park, JK Kim, BK Yoo, JD Rhee, Y Jahng CS Yong Physicochemical characterization of rutaecarpine-loaded microemulsion system, Drug Dev. Ind. Pharm. 31(7), 639-643 (2005.08.31)
23. 23E Ban, JH Cho, DJ Jang XL Piao, JK Kim, JP Jee, CK Kim, High-performance liquid chromatographic method for the pharmacokinetics study of acemetacin in human plasma. J. Liq. Chromatogr. & Rel. Tech. 28, 1593-1604 (2005.02.06).
24. 24MK Lee, SK Chun, WJ Choi, JK Kim, SH Choi, A Kim, K Oungbho, JS Park, WS Ahn, CK Kim, The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer. Biomaterials 26(14), 2147-2156 (2005.05.26)
25. 25CK Kim, KJ Yeon, E Ban, MJ Hyun, JK Kim, MK Kim, SE Jin, JS Park, Narrow-bore high performance liquid chromatographic method for the determination of cetirizine in human plasma using column switching J. Pharm. Biomed Anal. 37(3), 603-609 (2005.03.09)
26. 26DJ Jang JS Park, JP Jee, JK Kim, ST Kim, CK Kim, Simultaneous determination of niflumic acid and its prodrug talniflumate in human plasma by high performance liquid chromatography, Biomed. Chromatogr. 19(1),32-35 (2005.01.19)
27. 27WJ Choi, JK Kim, SH Choi, JS Park, WS Ahn, CK Kim, Low toxicity of cationic lipid-based emulsion for gene transfer, Biomaterials 25(27), 5893-5903 (2004.12.01)
28. 28YK Song, JE Maeng, HR Hwang, JS Park, BC Kim, JK Kim, CK Kim, Determination of glimepiride in human plasma using microbore high performance liquid chromatography with column-switching J. Chrmatogr. B 810(1), 143-149 (2004.10.15)
29. 29TH Park, JK Kim, JP Jee, JS Park, CK Kim, HPLC Method for simultaneous determination of cefprozil diastereomers in human plasma, J. Pharm. Biomed. Anal. 36(1), 243-246 (2004.09.21)
30. 30YK Song, JS Park, JK Kim, CK Kim, HPLC determination of dexamethasone in human plasma, J. Liq. Chromatogr. & Rel. Technol. 27(15), 2293-2306 (2004.03.31)
31. 31JK Kim, SH Choi, CO Kim, JS Park, WS Ahn, CK Kim, Enhancement of polyethylene glycol(PEG)-modified cationic liposome mediated gene delivery: effects on serum stability and transfection efficiency, J. Pharm. Pharmacol. 55(4). 453-460 (2003.04.01)

특허

HG Choi, CS Yong, KC Lee, DD Kim, DH Lee, CK Kim, JK Kim, MK Park, “Novel composite of gelatin ultra-micro capsule containing ibuprofen”, Korea Patent, No.10-0694235